Showing results (1121-1130 of 2,709) with videos related to
Sort By:
Pageof 271
The Lancet. Infectious Diseases|June 6, 2022
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort studySusana Monge, Ayelén Rojas-Benedicto, Carmen Olmedo, et al.The Lancet. Infectious Diseases|December 15, 2022
Viral dynamics in patients with monkeypox infection: a prospective cohort study in SpainClara Suñer, Maria Ubals, Eloy José Tarín-Vicente, et al.The Lancet. Infectious Diseases|May 8, 2022
Are we underestimating the annual risk of infection with Mycobacterium tuberculosis in high-burden settings?David W Dowdy, Marcel A BehrThe Lancet. Infectious Diseases|June 26, 2022
Global impact of the first year of COVID-19 vaccination: a mathematical modelling studyOliver J Watson, Gregory Barnsley, Jaspreet Toor, et al.The Lancet. Infectious Diseases|May 29, 2021
Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre studyThomas Bettuzzi, Aurélie Jourdes, Olivier Robineau, et al.The Lancet. Infectious Diseases|June 17, 2022
Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control studyM E Baarsma, Freek R van de Schoor, Stefanie A Gauw, et al.The Lancet. Infectious Diseases|September 11, 2020
Quantification and interpretation of attributable mortality in core clinical infectious disease journalsMaja von Cube, Jean-Francois Timsit, Marc Schumacher, et al.The Lancet. Infectious Diseases|December 10, 2020
Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2Eric A Meyerowitz, Aaron Richterman, Isaac I Bogoch, et al.The Lancet. Infectious Diseases|December 7, 2020
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trialAnanda S Bandyopadhyay, Chris Gast, Luis Rivera, et al.Pageof 271